Myopathies associated with systemic diseases.
D000437:Alcoholism / Q000150:complications; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002738:Chloroquine / Q000009:adverse effects; D003095:Collagen Diseases / Q000150:complications; D004700:Endocrine System Diseases / Q000150:complications; D004893:Erythema Nodosum / Q000150:complications; D005094:Exophthalmos / Q000150:complications; D005956:Glucose-6-Phosphate Isomerase; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications; D006980:Hyperthyroidism / Q000150:complications; D006996:Hypocalcemia / Q000150:complications; D007008:Hypokalemia / Q000150:complications; D007015:Hypophosphatemia, Familial / Q000150:complications; D007037:Hypothyroidism / Q000150:complications; D007273:Injections, Intramuscular; D007676:Kidney Failure, Chronic / Q000150:complications; D007773:Lactates / Q000097:blood; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications; D008614:Meperidine / Q000009:adverse effects; D008661:Metabolism, Inborn Errors / Q000150:complications; D009135:Muscular Diseases / Q000139:chemically induced / Q000201:enzymology / Q000209:etiology*; D009212:Myoglobinuria / Q000209:etiology; D009369:Neoplasms / Q000150:complications; D010243:Paralysis / Q000150:complications; D010732:Phosphofructokinase-1; D005082:Physical Exertion; D011773:Pyruvates / Q000097:blood; D012507:Sarcoidosis / Q000150:complications; D013256:Steroids / Q000009:adverse effects; D014652:Vascular Diseases / Q000150:complications
D000900:Anti-Bacterial Agents; D007773:Lactates; D011773:Pyruvates; D013256:Steroids; D002738:Chloroquine; D008614:Meperidine; D010732:Phosphofructokinase-1; D005956:Glucose-6-Phosphate Isomerase